Exact Mass: 667.2214024

KNI-272

C33H41N5O6S2 (667.2498126)

Kynostatin 272

C33H41N5O6S2 (667.2498126)

Sufugolix

C36H31F2N5O4S (667.206471)

C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2092 - Gonadotropin Releasing Hormone Antagonist

Peonidin acetyl 3,5-diglucoside

C30H35O17 (667.187416)

Peonidin acetyl 3,5-diglucoside is a member of the class of compounds known as anthocyanidin-5-o-glycosides. Anthocyanidin-5-o-glycosides are phenolic compounds containing one anthocyanidin moiety which is O-glycosidically linked to a carbohydrate moiety at the C5-position. Peonidin acetyl 3,5-diglucoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Peonidin acetyl 3,5-diglucoside can be found in common grape, which makes peonidin acetyl 3,5-diglucoside a potential biomarker for the consumption of this food product.

6-alpha-D-glucopyranosylalangiside

C31H41NO15 (667.2476076)

Reissantin C

C34H37NO13 (667.2264792000001)

Aristomanoside

C31H41NO15 (667.2476076)

3-O-beta-D-glucopyranosylalangiside

C31H41NO15 (667.2476076)

Peonidin acetyl 3,5-diglucoside

C30H35O17 (667.187416)

Peonidin 3-glucoside-5-(6-acetylglucoside)

C30H35O17 (667.187416)

6-O-beta-D-glucopyranosylalangiside

C31H41NO15 (667.2476076)

C31H41NO15

C31H41NO15 (667.2476076)

6-O-trans-Feruloyl-demethylalangiside

C34H37NO13 (667.2264792000001)

2-O-trans-feruloyldemethylalangiside

C34H37NO13 (667.2264792000001)

7-Hydroxypipotiazine glucuronide

C30H41N3O10S2 (667.2233246000001)

Peonidin acetyl 3,5-diglucoside

C30H35O17+ (667.187416)

cataCXium A-Pd-G2

C36H49ClNPPd (667.2325703999999)

Efonidipine (hydrochloride)

C34H39ClN3O7P (667.2214024)

Thiethylperazine malate

C30H41N3O10S2 (667.2233246000001)

D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent > C740 - Phenothiazine D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

Isepacin

C22H45N5O16S (667.258189)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins

Amikacin 2-phosphate

C22H46N5O16P+2 (667.2677046)

[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromenylium-3-yl]oxyoxan-2-yl]methyl acetate

C30H35O17+ (667.187416)

3-[[3-amino-4-(2-aminoethylcarbamoylamino)-2-methylpyrazol-1-ium-1-yl]methyl]-7-[[(2E)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C23H31N12O8S2+ (667.1829146000001)

Kynostatin 272

C33H41N5O6S2 (667.2498126)

D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

(6R,7R)-3-[[3-amino-4-(2-aminoethylcarbamoylamino)-2-methylpyrazol-1-ium-1-yl]methyl]-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C23H31N12O8S2+ (667.1829146000001)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

Guinee green B(1-)

C37H35N2O6S2- (667.1936430000001)

Peonidin 3-glucoside-5-(6-acetylglucoside)

C30H35O17+ (667.187416)

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(4-{[8-(1,2-dihydroxypropan-2-yl)-2-oxo-2H,8H,9H-furo[2,3-h]chromen-9-yl]oxy}-3-methyl-4-oxobutan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C29H37N3O13S (667.2046992)

Bemfivastatin (hemicalcium)

C34H36FN2O6.1/2Ca (667.1809088)

Bemfivastatin (PPD 10558) hemicalcium is an orally active lipid-lowering agent and HMG-CoA reductase inhibitor. Bemfivastatin hemicalcium enhances the activity of liver extracts. Bemfivastatin hemicalcium has no-observed adverse effect levels (NOAEL) with dosages of ≥320 mg/kg/d (rat developmental toxicity), ≥12.5 mg/kg/d (rabbit maternal toxicity), ≥25 mg/kg/d (rabbit developmental toxicity), respectively. Bemfivastatin hemicalcium can be used in the study of statin-related hypercholesterolemic myalgia in statin-intolerant patients.

Peonidin 3-glucoside-5-(6'-acetylglucoside)

C30H35O17 (667.187416)

aristomanoside

C31H41NO15 (667.2476076)

{"Ingredient_id": "HBIN016837","Ingredient_name": "aristomanoside","Alias": "NA","Ingredient_formula": "C31H41NO15","Ingredient_Smile": "COC1=C(C=CC(=C1)CCNC(=O)C=CC2=CC(=C(C=C2)OC3C(C(C(C(O3)CO)O)O)O)OC)OC4C(C(C(C(O4)CO)O)O)O","Ingredient_weight": "667.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1728","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11028762","DrugBank_id": "NA"}

4-ethenyl-7-hydroxy-8-methoxy-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

C31H41NO15 (667.2476076)

(3s,4s,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

C31H41NO15 (667.2476076)

(3s,4r,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

C31H41NO15 (667.2476076)

(3s,4s,4as,5ar)-3-{[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-4-ethenyl-7-hydroxy-8-methoxy-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

C31H41NO15 (667.2476076)

methyl (3s,12r)-19-{[(2s,3r,4s,5r,6s)-4,5-dihydroxy-3-methoxy-6-methyloxan-2-yl]amino}-3,5,15-trihydroxy-12-methoxy-7-methyl-2,13,17,20-tetraoxopentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),4,6,8,14,16(21),18-heptaene-6-carboxylate

C33H33NO14 (667.1900958000001)

4-ethenyl-8-hydroxy-7-methoxy-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

C31H41NO15 (667.2476076)

(1s,2r,5s,6s,7s,8s,9r,12s)-12-(acetyloxy)-5,7-bis(furan-3-carbonyloxy)-2-hydroxy-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl 1-methyl-6-oxopyridine-3-carboxylate

C34H37NO13 (667.2264792000001)

(3s,4r,4as,5ar)-3-{[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-4-ethenyl-7-hydroxy-8-methoxy-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

C31H41NO15 (667.2476076)

{6-[(4-ethenyl-7,8-dihydroxy-13-oxo-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-3-yl)oxy]-3,4,5-trihydroxyoxan-2-yl}methyl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C34H37NO13 (667.2264792000001)

12-(acetyloxy)-5,7-bis(furan-3-carbonyloxy)-2-hydroxy-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl 1-methyl-6-oxopyridine-3-carboxylate

C34H37NO13 (667.2264792000001)

(3s,4r,4as,5ar)-4-ethenyl-8-hydroxy-7-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

C31H41NO15 (667.2476076)

(2s,3r,4s,5s,6r)-2-{[(3s,4r,4as,5ar)-4-ethenyl-7,8-dihydroxy-13-oxo-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C34H37NO13 (667.2264792000001)

[(2r,3s,4s,5r,6s)-6-{[(3s,4r,4as,5ar)-4-ethenyl-7,8-dihydroxy-13-oxo-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C34H37NO13 (667.2264792000001)

(3s,4r,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

C31H41NO15 (667.2476076)

(2e)-3-(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-n-[2-(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethyl]prop-2-enimidic acid

C31H41NO15 (667.2476076)

[(2r,3s,4s,5r,6s)-6-{[(3s,4r,4as,5ar)-4-ethenyl-7,8-dihydroxy-13-oxo-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C34H37NO13 (667.2264792000001)

3-{[3,5-dihydroxy-6-(hydroxymethyl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-4-ethenyl-7-hydroxy-8-methoxy-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

C31H41NO15 (667.2476076)

(1s,2s,5s,6s,7r,8s,9r,12r)-12-(acetyloxy)-5,7-bis(furan-3-carbonyloxy)-2-hydroxy-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl 1-methyl-6-oxopyridine-3-carboxylate

C34H37NO13 (667.2264792000001)

methyl 19-[(4,5-dihydroxy-3-methoxy-6-methyloxan-2-yl)amino]-3,5,15-trihydroxy-12-methoxy-7-methyl-2,13,17,20-tetraoxopentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),4,6,8,14,16(21),18-heptaene-6-carboxylate

C33H33NO14 (667.1900958000001)

2-[(4-ethenyl-7,8-dihydroxy-13-oxo-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-3-yl)oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C34H37NO13 (667.2264792000001)

(3s,4s,4as,5ar)-4-ethenyl-7-hydroxy-8-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one

C31H41NO15 (667.2476076)

5-{[(2s,3r,4s,5r,6s)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1λ⁴-chromen-1-ylium

[C30H35O17]+ (667.187416)